✦ LIBER ✦

Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome

✍ Scribed by Jonathan L Isaacsohn; August J Troendle; David G Orloff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dyslipidemia in the metabolic syndrome a

✍ John D Brunzell; Amir F Ayyobi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Combination therapy of dyslipidemia in n

✍ Christopher M. Rembold 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 190 KB

The Obesity, Metabolic Syndrome, and Typ

✍ Henry N. Ginsberg; Paul R. MacCallum 📂 Article 📅 2009 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 155 KB

The Obesity, Metabolic Syndrome, and Typ

✍ Henry N. Ginsberg; Paul R. MacCallum 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 271 KB

Nonpharmacologic Management of Mixed Dys

✍ Neil J. Stone 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 156 KB

New drug targets for type 2 diabetes and

✍ Moller, David E. 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 506 KB